What's new

[Cyprus Times] Covid-19: These mutations were detected in Cyprus

ergastirio-koronoios-e1640698439395.jpg

These mutations were detected in Cyprus The Ministry of Health informs

Almost all covid-19 mutations have been detected in Cyprus so far.

The Ministry of Health publishes the results of tests on samples sent for sequencing.

In detail:

The Ministry of Health informs that a SARS-CoV-2 genomic surveillance system is operating in Cyprus under the coordination of the Unit for Epidemiological Surveillance and Control of Infectious Diseases. Through the system, weekly sequencing of the complete genome of SARS-CoV-2 virus is performed on randomly selected and/or targeted samples.

For the period 1 September 2022 to 15 October 2022, successful sequencing was performed in 194 samples identified as Omicron (B.1.1.529). Of these samples, 4 (2.1%) were identified as BA.2, 1 (0.5%) as BA.4 and 189 (97.4%) as BA.5In particular, of these strains, some sub-strains have been identified as Variant under Monitoring (VUM) according to the World Health Organization. In particular, 3 sequences of BQ1 and its evolutionary sub-strains, 10 sequences of BF.7 and its evolutionary sub-strains, 1 sequence of BN1.3 which is an evolutionary sub-strain of BA.2.75, 1 sequence of BA.4.6 and 3 sequences of BA.2.3.20.

BQ.1, including its evolutionary substrains, has been classified by the ECDC as a Variant of interest (VOI) since 20 October 2022 and has already been detected at significant levels in several Member States. However, it should be noted that BQ.1 levels in our country are currently at low levels.



From modelling estimates by the ECDC, it is expected that it is likely that the proportion of BQ.1 in the coming period across Europe. Based on the data available so far, there is no evidence that BQ.1 is associated with higher infection severity than the circulating BA.4/BA.5 variants.

It is stressed that all approved vaccines currently available in Cyprus protect against severe disease and death against all known variants.

In addition, it is recalled that available antiviral drugs continue to be effective if administered in a timely manner, reducing the severity of symptoms and thus the risk of hospitalisation.


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top